These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26478017)

  • 1. Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer.
    Li WM; Chiang CS; Huang WC; Su CW; Chiang MY; Chen JY; Chen SY
    J Control Release; 2015 Dec; 220(Pt A):107-118. PubMed ID: 26478017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ DOX-calcium phosphate mineralized CPT-amphiphilic gelatin nanoparticle for intracellular controlled sequential release of multiple drugs.
    Li WM; Su CW; Chen YW; Chen SY
    Acta Biomater; 2015 Mar; 15():191-9. PubMed ID: 25542535
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In situ doxorubicin-CaP shell formation on amphiphilic gelatin-iron oxide core as a multifunctional drug delivery system with improved cytocompatibility, pH-responsive drug release and MR imaging.
    Li WM; Chen SY; Liu DM
    Acta Biomater; 2013 Feb; 9(2):5360-8. PubMed ID: 23022876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lung cancer therapy using doxorubicin and curcumin combination: Targeted prodrug based, pH sensitive nanomedicine.
    Hong Y; Che S; Hui B; Yang Y; Wang X; Zhang X; Qiang Y; Ma H
    Biomed Pharmacother; 2019 Apr; 112():108614. PubMed ID: 30798129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-Responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells.
    Gao C; Tang F; Gong G; Zhang J; Hoi MPM; Lee SMY; Wang R
    Nanoscale; 2017 Aug; 9(34):12533-12542. PubMed ID: 28819666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Core-Interlayer-Shell DOX/ZnPc Co-loaded MSNs@ pH-Sensitive CaP@PEGylated Liposome for Enhanced Synergetic Chemo-Photodynamic Therapy.
    Ma J; Wu H; Li Y; Liu Z; Liu G; Guo Y; Hou Z; Zhao Q; Chen D; Zhu X
    Pharm Res; 2018 Feb; 35(3):57. PubMed ID: 29423532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas.
    Fang JH; Lai YH; Chiu TL; Chen YY; Hu SH; Chen SY
    Adv Healthc Mater; 2014 Aug; 3(8):1250-60. PubMed ID: 24623647
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual stimuli-responsive polypeptide-calcium phosphate hybrid nanoparticles for co-delivery of multiple drugs in cancer therapy.
    Li Q; Fu D; Zhang J; Yan H; Wang H; Niu B; Guo R; Liu Y
    Colloids Surf B Biointerfaces; 2021 Apr; 200():111586. PubMed ID: 33529927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment.
    Cui T; Zhang S; Sun H
    Oncol Rep; 2017 Feb; 37(2):1253-1260. PubMed ID: 28075466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-step formation of lipid-polyacrylic acid-calcium carbonate nanoparticles for co-delivery of doxorubicin and curcumin.
    Peng J; Fumoto S; Miyamoto H; Chen Y; Kuroda N; Nishida K
    J Drug Target; 2017 Sep; 25(8):704-714. PubMed ID: 28368667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzyme and Thermal Dual Responsive Amphiphilic Polymer Core-Shell Nanoparticle for Doxorubicin Delivery to Cancer Cells.
    Kashyap S; Singh N; Surnar B; Jayakannan M
    Biomacromolecules; 2016 Jan; 17(1):384-98. PubMed ID: 26652038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium phosphate coated core-shell protein nanocarriers: Robust stability, controlled release and enhanced anticancer activity for curcumin delivery.
    Wu Q; Gao H; Vriesekoop F; Liu Z; He J; Liang H
    Mater Sci Eng C Mater Biol Appl; 2020 Oct; 115():111094. PubMed ID: 32600698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effective combination therapy against human osteosarcoma: doxorubicin plus curcumin co-encapsulated lipid-coated polymeric nanoparticulate drug delivery system.
    Wang L; Wang W; Rui Z; Zhou D
    Drug Deliv; 2016 Nov; 23(9):3200-3208. PubMed ID: 26987435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice.
    Zhao X; Chen Q; Li Y; Tang H; Liu W; Yang X
    Eur J Pharm Biopharm; 2015 Jun; 93():27-36. PubMed ID: 25770771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The tumor accumulation and therapeutic efficacy of doxorubicin carried in calcium phosphate-reinforced polymer nanoparticles.
    Min KH; Lee HJ; Kim K; Kwon IC; Jeong SY; Lee SC
    Biomaterials; 2012 Aug; 33(23):5788-97. PubMed ID: 22591612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of cancer therapy efficacy by trastuzumab-conjugated and pH-sensitive nanocapsules with the simultaneous encapsulation of hydrophilic and hydrophobic compounds.
    Chiang CS; Hu SH; Liao BJ; Chang YC; Chen SY
    Nanomedicine; 2014 Jan; 10(1):99-107. PubMed ID: 23891983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer.
    Zhang Y; Yang C; Wang W; Liu J; Liu Q; Huang F; Chu L; Gao H; Li C; Kong D; Liu Q; Liu J
    Sci Rep; 2016 Feb; 6():21225. PubMed ID: 26876480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistically Improved Anti-tumor Efficacy by Co-delivery Doxorubicin and Curcumin Polymeric Micelles.
    Wang J; Ma W; Tu P
    Macromol Biosci; 2015 Sep; 15(9):1252-61. PubMed ID: 25981672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Co-delivery of doxorubicin and RNA using pH-sensitive poly (β-amino ester) nanoparticles for reversal of multidrug resistance of breast cancer.
    Tang S; Yin Q; Zhang Z; Gu W; Chen L; Yu H; Huang Y; Chen X; Xu M; Li Y
    Biomaterials; 2014 Jul; 35(23):6047-59. PubMed ID: 24797883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Triple Therapy of HER2
    Zolata H; Afarideh H; Davani FA
    Cancer Biother Radiopharm; 2016 Nov; 31(9):324-329. PubMed ID: 27831759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.